• Exchange: OTC BB
  • Sector: Materials
  • Industry: Chemicals
  • Sub-Industry: Specialty Chemicals

Arch Therapeutics Inc

+ Add to Watchlist

ARTH:US

0.1950 USD 0.0050 2.50%

As of 20:10:04 ET on 12/26/2014.

Snapshot for Arch Therapeutics Inc (ARTH)

Open: 0.1950 Day's Range: 0.1900 - 0.2000 Volume: 104,900
Previous Close: 0.2000 52wk Range: 0.1500 - 0.4540 1-Yr Rtn: -22.00%

Stock Chart for ARTH

No chart data available.
  • ARTH:US 0.1950
  • 1D
  • 1M
  • 1Y
0.2000
Interactive ARTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARTH

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0800
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 14.83
Shares Outstanding (M) 76.08
30 Day Average Volume 150,592
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARTH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARTH

Arch Therapeutics, Inc. operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding.

Terrence W NorchiPresident/CEO/Co-FounderRichard E DavisCFO/Treasurer
William M Cotter "Bill"Chief Operating Officer
More Company Profile & Key Executives for ARTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil